medical device investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
medical device investing ChroMedX Appoints Michaela Shaw as Director of Quality Assurance and Regulatory Assurance
medical device investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
medical device investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
medical device investing ChroMedX Appoints Raj Kailasanathan as Executive Vice President Corporate Finance
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
